Mast Therapeutics (MSTX) Tops Q3 EPS by 1c

November 8, 2016 9:01 AM EST
Get Alerts MSTX Hot Sheet
Trade MSTX Now!
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 2-week free trial to StreetInsider Premium here.

Mast Therapeutics (NYSE: MSTX) reported Q3 EPS of ($0.04), $0.01 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $45 thousand versus the consensus estimate of $0 .

For earnings history and earnings-related data on Mast Therapeutics (MSTX) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment